Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-09-10 Sale | 2021-09-14 4:08 pm | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 12,500 | $50 | $625,000 | 271,321 (Direct) | View |
2021-07-29 Sale | 2021-08-02 6:49 pm | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 12,500 | $45 | $562,500 | 283,821 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-09-16 Exercise | 2024-09-17 5:11 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 2,250 | $0 | 68,090 (Direct) | View |
2024-09-16 Tax Withholding | 2024-09-17 5:11 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 661 | $6.36 | 68,090 (Direct) | View |
2024-03-07 Disposition | 2024-03-08 7:19 pm | N/A 2031-02-10 | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 174,850 | $0 | 174,850 (Direct) | View |
2024-03-07 Option Award | 2024-03-08 7:19 pm | N/A 2031-02-10 | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 174,850 | $0 | 174,850 (Direct) | View |
2024-02-13 Tax Withholding | 2024-02-15 5:07 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 1,735 | $6.53 | 175,051 (Direct) | View |
2024-02-14 Option Award | 2024-02-15 5:07 pm | N/A 2034-02-13 | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 150,100 | $0 | 175,051 (Direct) | View |
2023-09-18 Option Award | 2023-09-19 7:22 pm | N/A 2033-09-17 | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 120,000 | $0 | 120,000 (Direct) | View |
2023-08-30 Exercise | 2023-08-31 4:12 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 2,250 | $0 | 43,186 (Direct) | View |
2023-08-30 Tax Withholding | 2023-08-31 4:12 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 661 | $2.93 | 43,186 (Direct) | View |
2023-02-13 Option Award | 2023-02-15 4:45 pm | N/A 2033-02-12 | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 110,000 | $0 | 115,097 (Direct) | View |
2023-01-30 Exercise | 2023-02-01 4:09 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 3,750 | $0 | 23,847 (Direct) | View |
2023-01-30 Tax Withholding | 2023-02-01 4:09 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 1,301 | $7.78 | 23,847 (Direct) | View |
2022-05-26 Tax Withholding(A) | 2022-06-14 4:45 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 1,102 | $7.01 | 2,648 (Direct) | View |
2022-05-25 Exercise | 2022-05-27 4:16 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 3,750 | $0 | 26,250 (Direct) | View |
2022-02-14 Option Award | 2022-02-16 4:30 pm | N/A 2032-02-13 | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 116,250 | $0 | 116,250 (Direct) | View |
2021-09-10 Exercise | 2021-09-14 4:08 pm | N/A 2030-07-02 | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 12,500 | $0 | 271,321 (Direct) | View |
2021-09-10 Exercise | 2021-09-14 4:08 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 12,500 | $4.98 | 271,321 (Direct) | View |
2021-07-29 Exercise | 2021-08-02 6:49 pm | N/A 2030-07-02 | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 12,500 | $0 | 283,821 (Direct) | View |
2021-07-29 Exercise | 2021-08-02 6:49 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 12,500 | $4.98 | 283,821 (Direct) | View |
2021-02-11 Option Award | 2021-02-16 4:15 pm | N/A 2031-02-10 | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 84,850 | $0 | 84,850 (Direct) | View |
Ownership | 2020-10-01 9:22 pm | N/A 2030-07-02 | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 0 | $0 | 296,321 (Direct) | View |
2020-05-06 Disposition | 2020-05-06 9:06 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | Siegel Jolie VP, General Counsel | 321,821 | $0 | 0 (Direct) | View |
2020-02-29 Tax Withholding | 2020-03-02 6:39 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | Siegel Jolie VP, General Counsel | 2,845 | $1.5 | 161,821 (Direct) | View |
2020-02-25 Tax Withholding | 2020-02-27 6:21 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | Siegel Jolie VP, General Counsel | 5,334 | $1.51 | 164,666 (Direct) | View |
2020-01-12 Option Award | 2020-01-13 5:27 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | Siegel Jolie VP, General Counsel | 65,000 | $0 | 170,000 (Direct) | View |
2019-11-25 Option Award | 2019-11-25 5:25 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | Siegel Jolie VP, General Counsel | 75,000 | $0 | 105,000 (Direct) | View |